Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group (Q73253906)
Jump to navigation
Jump to search
scientific article published on 01 November 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group |
scientific article published on 01 November 1999 |
Statements
Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group (English)
B D Kahan
B A Julian
M D Pescovitz
Y Vanrenterghem